Steven A Rosenberg

Steven A Rosenberg

UNVERIFIED PROFILE

Are you Steven A Rosenberg?   Register this Author

Register author
Steven A Rosenberg

Steven A Rosenberg

Publications by authors named "Steven A Rosenberg"

Are you Steven A Rosenberg?   Register this Author

100Publications

4072Reads

20Profile Views

Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities.

J Invest Dermatol 2019 Sep 21;139(9):1985-1992.e10. Epub 2019 Mar 21.

Laboratory of Molecular Cancer Biology, Molecular Physiology Research Unit (URPHYM), Namur Research Institute for Life Sciences, Faculty of Medicine, Department of Biomedical Sciences, University of Namur, Namur, Belgium. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0022202X193133
Publisher Site
http://dx.doi.org/10.1016/j.jid.2019.01.036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708748PMC
September 2019

Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer.

J Immunol 2019 Jun 29;202(12):3458-3467. Epub 2019 Apr 29.

Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1801022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548619PMC
June 2019

BRAF Inhibition: Bridge or Boost to T-cell Therapy?

Clin Cancer Res 2019 May 1;25(9):2682-2684. Epub 2019 Mar 1.

Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-0286DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497532PMC
May 2019

Carl N. Zimet (1925-2015).

Am Psychol 2017 May-Jun;72(4):401

University of Colorado School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1037/amp0000126DOI Listing
June 2018

Influence of family demographic factors on social communication questionnaire scores.

Autism Res 2018 05 9;11(5):695-706. Epub 2018 Feb 9.

Department of Mental Health and Wendy Klag Center for Autism and Developmental Disabilities, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/aur.1935DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992034PMC
May 2018

An Efficient Single-Cell RNA-Seq Approach to Identify Neoantigen-Specific T Cell Receptors.

Mol Ther 2018 02 28;26(2):379-389. Epub 2017 Oct 28.

Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2017.10.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835023PMC
February 2018

Screening for Autism with the SRS and SCQ: Variations across Demographic, Developmental and Behavioral Factors in Preschool Children.

J Autism Dev Disord 2017 Nov;47(11):3550-3561

Departments of Psychiatry and Pediatrics, University of Colorado Anschutz Medical Campus, Mailstop C234, 13121 E 17th Ave, Aurora, CO, 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10803-017-3255-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743015PMC
November 2017

Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3.

J Clin Oncol 2017 Oct 15;35(29):3322-3329. Epub 2017 Aug 15.

Yong-Chen Lu, Linda L. Parker, Tangying Lu, Zhili Zheng, Mary Ann Toomey, Donald E. White, Xin Yao, Yong F. Li, Paul F. Robbins, Steven A. Feldman, Christopher A. Klebanoff, Stephanie L. Goff, Richard M. Sherry, Udai S. Kammula, James C. Yang, and Steven A. Rosenberg, National Cancer Institute, Bethesda, MD; Pierre van der Bruggen, Ludwig Institute for Cancer Research; De Duve Institute, Université Catholique de Louvain, Brussels; and Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wallonia, Belgium; Christopher A. Klebanoff, Memorial Sloan Kettering Cancer Center, Parker Institute for Cancer Immunotherapy, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.5463DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652397PMC
October 2017

Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels.

J Clin Oncol 2017 Jun 14;35(16):1803-1813. Epub 2017 Mar 14.

James N. Kochenderfer, Robert P.T. Somerville, Tangying Lu, Victoria Shi, Stephanie L. Goff, James C. Yang, Richard M. Sherry, Christopher A. Klebanoff, Udai S. Kammula, Constance M. Yuan, Mark J. Roschewski, Steven A. Feldman, Lori McIntyre, Mary Ann Toomey, and Steven A. Rosenberg, National Cancer Institute, National Institutes of Health, Bethesda, MD; Adrian Bot, John Rossi, Allen Xue, Marika Sherman, and Arianne Perez, Kite Pharma, Santa Monica, CA; Tatyana Feldman, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ; and Jonathan W. Friedberg, University of Rochester School of Medicine, Rochester, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.3024
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.3024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455597PMC
June 2017

Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients.

Ann Surg Oncol 2017 Apr 31;24(4):947-951. Epub 2017 Jan 31.

Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-017-5768-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339323PMC
April 2017

LIGHT Elevation Enhances Immune Eradication of Colon Cancer Metastases.

Cancer Res 2017 04 1;77(8):1880-1891. Epub 2017 Mar 1.

Department of Surgery, Division of Surgical Oncology, University of Illinois at Chicago, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-16-1655DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410174PMC
April 2017

'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations.

Nat Immunol 2017 02;18(3):255-262

Surgery Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni.3682DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295671PMC
February 2017

T-Cell Transfer Therapy Targeting Mutant KRAS.

N Engl J Med 2017 02;376(7):e11

National Cancer Institute, Bethesda, MD

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697099PMC
February 2017

T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.

N Engl J Med 2016 Dec;375(23):2255-2262

From the Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1609279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5178827PMC
December 2016

Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma.

Clin Cancer Res 2016 Nov 1;22(22):5480-5486. Epub 2016 Aug 1.

Molecular Diagnostics Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-0613DOI Listing
November 2016

Adoptive T-Cell Therapy for Cancer.

Adv Immunol 2016 3;130:279-94. Epub 2016 Feb 3.

Center for Clinical Research, National Cancer Institute, Bethesda, MD, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.ai.2015.12.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293459PMC
October 2016

Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma.

J Clin Oncol 2016 07 23;34(20):2389-97. Epub 2016 May 23.

Stephanie L. Goff, Deborah E. Citrin, Robert P. Somerville, John R. Wunderlich, David N. Danforth, James C. Yang, Richard M. Sherry, Udai S. Kammula, Christopher A. Klebanoff, Marybeth S. Hughes, Nicholas P. Restifo, Michelle M. Langhan, Thomas E. Shelton, Lily Lu, Mei Li M. Kwong, Sadia Ilyas, Nicholas D. Klemen, Eden C. Payabyab, Kathleen E. Morton, Mary Ann Toomey, Seth M. Steinberg, Donald E. White, and Steven A. Rosenberg, National Cancer Institute, National Institutes of Health; Daniel A. Zlott, Clinical Center, National Institutes of Health, Bethesda, MD; and Mark E. Dudley, Novartis Institutes for BioMedical Research, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.7220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981979PMC
July 2016

Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System.

Mol Ther 2016 06 5;24(6):1078-1089. Epub 2016 Mar 5.

Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15250016163037
Publisher Site
http://dx.doi.org/10.1038/mt.2016.51DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923320PMC
June 2016

Isolation and Characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-Cell Receptor for Cancer Immunotherapy.

J Immunother 2016 06;39(5):191-201

*Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD †Cellular Biomedicine Group Inc., Cupertino, CA ‡Ludwig Institute for Cancer Research and WELBIO §De Duve Institute, Université Catholique de Louvain, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000123DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947411PMC
June 2016

MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases.

J Immunother 2016 May;39(4):181-7

*Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN †Laboratory of Pathology ‡Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831141PMC
May 2016

Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.

J Clin Oncol 2016 Apr 25;34(10):1112-21. Epub 2016 Jan 25.

Jennifer N. Brudno, Robert P.T. Somerville, Victoria Shi, Jeremy J. Rose, David C. Halverson, Daniel H. Fowler, Juan C. Gea-Banacloche, Steven Z. Pavletic, Dennis D. Hickstein, Tangying L. Lu, Steven A. Feldman, Alexander T. Iwamoto, Brenna G. Hansen, Bazetta Blacklock-Schuver, Frances T. Hakim, Steven A. Rosenberg, Ronald E. Gress, and James N. Kochenderfer, National Cancer Institute; Roger Kurlander and Irina Maric, National Institutes of Health, Bethesda; Jennifer S. Wilder, Frederick National Laboratory for Cancer Research, Frederick, MD; and Andre Goy, John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.5929DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872017PMC
April 2016

Identifying Infants and Toddlers at High Risk for Persistent Delays.

Matern Child Health J 2016 Mar;20(3):639-45

Department of Psychiatry, University of Colorado School of Medicine, Aurora, CO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10995-015-1863-2DOI Listing
March 2016

Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers.

J Immunother 2016 Jan;39(1):1-7

*Surgery Branch †Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453128PMC
January 2016

Prospects for gene-engineered T cell immunotherapy for solid cancers.

Nat Med 2016 Jan;22(1):26-36

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.4015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295670PMC
January 2016

Immunogenicity of somatic mutations in human gastrointestinal cancers.

Science 2015 Dec 29;350(6266):1387-90. Epub 2015 Oct 29.

Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aad1253DOI Listing
December 2015

Adoptive Cell Therapy--Tumor-Infiltrating Lymphocytes, T-Cell Receptors, and Chimeric Antigen Receptors.

Semin Oncol 2015 Aug 12;42(4):626-39. Epub 2015 Jun 12.

Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2015.05.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295669PMC
August 2015

Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.

J Virol 2015 Jul 15;89(13):6685-94. Epub 2015 Apr 15.

Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.00474-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468509PMC
July 2015

Using standardized diagnostic instruments to classify children with autism in the study to explore early development.

J Autism Dev Disord 2015 May;45(5):1271-80

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 1600 Clifton Road MS E-86, Atlanta, GA, 30333, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10803-014-2287-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486213PMC
May 2015

Adoptive cell transfer as personalized immunotherapy for human cancer.

Science 2015 Apr;348(6230):62-8

Surgery Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, 9000 Rockville Pike, CRC Building, Room 3W-3940, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aaa4967DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295668PMC
April 2015

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.

J Clin Oncol 2015 Feb 25;33(6):540-9. Epub 2014 Aug 25.

James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim, Robert P.T. Somerville, Robert O. Carpenter, Maryalice Stetler-Stevenson, James C. Yang, Q. Phan, Marybeth S. Hughes, Richard M. Sherry, Mark Raffeld, Steven Feldman, Lily Lu, Yong F. Li, Lien T. Ngo, Debbie-Ann N. Nathan, Kathleen E. Morton, Mary Ann Toomey, and Steven A. Rosenberg, National Cancer Institute; Clara C. Chen, Clinical Center, National Institutes of Health (NIH); Sarah M. Kranick and Avindra Nath, National Institutes of Neurologic Disorders and Stroke, NIH, Bethesda, MD; Andre Goy and Tatyana Feldman, Hackensack University Medical Center, Hackensack, NJ; David E. Spaner, Sunybrook Odette Cancer Center, Toronto, Ontario, Canada; and Michael L. Wang, MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.2025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322257PMC
February 2015

Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.

J Clin Oncol 2015 Jan 17;33(1):74-82. Epub 2014 Nov 17.

Kevin C. Conlon, Steven A. Rosenberg, Antonio Tito Fojo, John C. Morris, Thomas A. Fleisher, Sigrid P. Dubois, Liyanage P. Perera, Donn M. Stewart, Carolyn K. Goldman, Bonita R. Bryant, Jean M. Decker, Jing Chen, Tat'Yana A. Worthy, William D. Figg Sr, Cody J. Peer, and Thomas A. Waldmann, National Cancer Institute; Enrico Lugli, Hugh C. Welles, Michael C. Sneller, H. Clifford Lane, and Mario Roederer, National Institute of Allergy and Infectious Diseases, Bethesda; Jason L. Yovandich and Stephen P. Creekmore, National Cancer Institute, Frederick, MD; and Hugh C. Welles, Columbian College of Arts and Sciences, George Washington University, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.3329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268254PMC
January 2015

Mutational and functional analysis of the tumor-suppressor PTPRD in human melanoma.

Hum Mutat 2014 Nov 10;35(11):1301-10. Epub 2014 Sep 10.

National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.22630DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394620PMC
November 2014

Decade in review-cancer immunotherapy: entering the mainstream of cancer treatment.

Nat Rev Clin Oncol 2014 Nov 14;11(11):630-2. Epub 2014 Oct 14.

National Cancer Institute, 10 Center Drive MSC 1201, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2014.174DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310157PMC
November 2014

Somatic mutation of GRIN2A in malignant melanoma results in loss of tumor suppressor activity via aberrant NMDAR complex formation.

J Invest Dermatol 2014 Sep 16;134(9):2390-2398. Epub 2014 Apr 16.

Cancer Genetics Branch, National Human Genetics Research Institute, National Institutes of Health, Bethesda, Maryland, USA; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0022202X153695
Publisher Site
http://dx.doi.org/10.1038/jid.2014.190DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134353PMC
September 2014

Specific increase in potency via structure-based design of a TCR.

J Immunol 2014 Sep 28;193(5):2587-99. Epub 2014 Jul 28.

Perlmutter Cancer Center, New York University School of Medicine, New York, NY 10016; Program in Structural Biology, New York University School of Medicine, New York, NY 10016; Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, NY 10016

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1302344DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205480PMC
September 2014

Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells.

J Immunother Cancer 2014 19;2:25. Epub 2014 Aug 19.

Surgery Branch, Center for Cancer Research, National Cancer Institute, 10 Center Drive, Building 10 Hatfield CRC, Rm 3-5930, 20892-1201 Bethesda, MD, USA ; Current address: Bluebird bio, 150 Second St, Cambridge, MA 02141, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2051-1426-2-25DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155770PMC
September 2014

T-cell therapy against cancer mutations.

Oncotarget 2014 Jul;5(13):4579-80

Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148085PMC
http://dx.doi.org/10.18632/oncotarget.2234DOI Listing
July 2014

IL-2: the first effective immunotherapy for human cancer.

J Immunol 2014 Jun;192(12):5451-8

Surgery Branch, National Cancer Institute, Bethesda, MD 20892

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1490019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293462PMC
June 2014

Pancreatic cancer: Hurdles in the engineering of CAR-based immunotherapies.

Oncoimmunology 2014 18;3:e29194. Epub 2014 Jun 18.

bluebird bio; Cambridge, MA USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.29194DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108460PMC
June 2014

Melanoma: Why is sentinel lymph node biopsy 'standard of care' for melanoma?

Nat Rev Clin Oncol 2014 May 15;11(5):245-6. Epub 2014 Apr 15.

Surgery Branch, Center for Cancer Research, National Cancer Institute, CRC Room 3-5952, 9000 Rockville Pike, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2014.65DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453120PMC
May 2014